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Background: Typhoid fever remains a serious public
health problem in Egypt. In Fayoum governorate, where the
annual incidence is 0.1%, population-based studies showed
that unsafe water storage and lack of hygienic practices
are risk factors for infection. To reduce transmission, a
community-based intervention campaign was implemented
in 12 randomly selected villages in Fayoum to promote safe
water storage and hand hygiene practices. The campaign
included personal communications, village-wide meetings,
and distribution of educational materials. The objective was
to measure the impact of the campaign on the knowledge
and behavior of caregivers in the household.
Methods: Two separate random samples of households
were chosen and surveyed before and after the commu-
nity intervention. Caregivers within the selected households
were interviewed in each targeted village. Data was col-
lected on knowledge of typhoid fever symptoms, methods
of prevention and proper management of illness. Household
water storage and hand hygiene practices were observed
Results: We interviewed 942 caregivers at baseline and
conducted a ﬁnal evaluation of 764 caregivers in the same
villages. In the pre-intervention survey, 36% of caregivers
reported proper knowledge of symptoms and management
of typhoid compared to 94% following the intervention
(P < 0.0001). Similarly, the proportion of caregivers who
demonstrated proper hand washing technique increased
from 2% to 42% (P < 0.0001). The proportion of care-
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Background: From the data collected at the Ministry of
Health from whole nation public and private blood banks
(BB) ﬁnd out the proportion of blood units discarded for
being seropositive HBV, HCV, HIV, syphilis and Trypanosoma
cruzi, and the seroprevalence of these infections among
their donors.
Methods: ELISA serological testing was done with 715,
393 donors seen at 535 blood banks between 2001 and
2002. Samples that were repeat reactive (RR) with the ELISA
underwent supplementary Western blot (WB) testing.
Results: Of the 715, 393 blood banks donors, 9,294 of
them (1.3%) were positive for syphilis (VDRL), 6,107 (0.85%)
for HBV (anti-HBc), 4,825 (0,67%) for T. cruzi, 3,859 (0.54%)
for HCV and 1, 870 (0.26%) for HIV. In the Figure a summary
of the seroprevalence of these infections, among public and
private blood banks, per year, is presented.
Conclusion: Although syphilis or Treponema pallidum
infection was the most important blood-borne disease found
in this study, the seroprevalence found is lower than oth-
ers reported in other countries in the region (e.g. Goiânia,
Brazil, 1989, 4.1%). For HBV and HCV, the seroprevalence
estimates were also similar than those found in other coun-
tries in the region (such as Río de Janeiro, Brazil, where in
2005 the anti-HBc was 2.05% and 0.79% in 2004 for HCV),
indicating high rates of infection by HBV and HCV and a per-
sistent risk of HBV and HCV transmission by transfusion. For
Chagas disease is also lower than others reported in other
countries in the region (e.g. Goiânia, Brazil, 1989, 3.3%).
Finally for HIV the found seroprevalence is similar to that
reported in Mexico (Irapuato, Mexico, 2003,0.24%). But as
seen herein, those seroprevalences are regional, and our
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Background: In 1992, the World Health Assembly passed
resolution 45.17 calling for Member States, ‘‘. . .to integrate
cost-effective new vaccines, such as hepatitis B vaccine,
into national immunization programs in countries where it is
feasible. . .’’ The same year, the World Health Organization
(WHO) recommended that all countries integrate hepatitis
B vaccine (HepB) into national immunization programs by
1997. Unfortunately these goals were not met, mostly due
to ﬁnancial barriers; by 1997 only 65 Member States had
introduced HepB nationwide. Following creation of the GAVI
Alliance in 2000, ﬁnancial support was made available to
the less developed member states and Alliance partners set
new milestones calling for HepB to be introduced in these
countries 2007.
Methods: We reviewed programmatic data reported to
WHO as part of the Joint Reporting Form to determine the
number of countries that provide HepB and the coverage of
this vaccine. Data were analyzed to provide information on
program achievements over time
Results: As of 2006, 164 of 193 (85%) WHO Member States
reported having integrated HepB into their routine infant
immunization schedules. The remaining 29 countries include
those with historically low HBV prevalence and those coun-
tries gradually introducing HepB. The remaining countries
include 14 GAVI-eligible countries, of which the majority
(10) are in the WHO Africa Region (AFR). Global coverage of
three doses of hepatitis B vaccine in 2006 was 60%, compared
